Sitryx Competitors and Similar CompaniesClear all
Oncologie's competitors and similar companies include ArunA Bio.
 ArunA Bio ArunA Bio is engaged in advancing a new class of cell-free biologics, exosomes, for the treatment of central nervous system (CNS) and neurodegenerative disorders and leveraging a platform to optimize the delivery of RNAs, antibodies, genes and small molecules. | ||
Founding Date | Founding Date 2018 | Founding Date 2003 |
Type | Type Private | Type Private |
Tags | ||
Locations | Locations Waltham, US HQ Shanghai, CN Boston, US | Locations Athens, US HQ Athens, US |
Employees | Employees 8 | Employees 274% increase |
Funding | ||
Latest funding round | Latest funding round $ 80m (almost 7 years ago) | Latest funding round $ 4.5m (over 6 years ago) |
Total funding raised | Total funding raised $ 96.5m | Total funding raised $ 26.9m |
For sources of this data, please see the company profile
View Company Profiles
ArunA Bio
HQ
Athens, US
Employees
27↑ 4% increase
ArunA Bio is engaged in advancing a new class of cell-free biologics, exosomes, for the treatment of central nervous system (CNS) and neurodegenerative disorders and leveraging a platform to optimize the delivery of RNAs, antibodies, genes and small molecules.
View company